Furosemide Injection, Solution
NDC Package 70756-620-10

11-digit billing NDC: 70756062010
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Furosemide injection is parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.Edema: Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. This formulation utilizes a injection, solution delivery system. Marketed by Lifestar Pharma Llc, this product is identified by NDC 70756-620 and is authorized under FDA application ANDA216860.

Identification & Billing

NDC Package Code
70756-620-10
Package Description
10 VIAL in 1 CARTON / 10 mL in 1 VIAL (70756-620-86)
Product Code
70756-620
11-Digit Billing Format
70756062010
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Furosemide
Non-Proprietary Name
Furosemide
Substance Name
Furosemide
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
FUROSEMIDE 10 mg/mL
Pharmacologic Class
Usage Information
Parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.Edema: Furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. Furosemide is particularly useful when an agent with greater diuretic potential is desired.Furosemide is indicated as adjunctive therapy in acute pulmonary edema. The intravenous administration of furosemide is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema.If gastrointestinal absorption is impaired or oral medication is not practical for any reason, furosemide is indicated by the intravenous or intramuscular route. Parenteral use should be replaced with oral furosemide as soon as practical.

Regulatory & Marketing

Labeler Name
Lifestar Pharma Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA216860
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-17-2022
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70756-620). Click a package code to view its specific billing and regulatory data.

70756-620-25
25 VIAL in 1 CARTON / 10 mL in 1 VIAL (70756-620-86)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70756-620-10 identifies a specific commercial package of 10 vial in 1 carton / 10 ml in 1 vial (70756-620-86) of Furosemide, a human prescription drug labeled by Lifestar Pharma Llc. This injection, solution is formulated for intravenous use and contains furosemide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Lifestar Pharma Llc on December 17, 2022. The current certification is valid through December 31, 2027.

How is this Lifestar Pharma Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70756062010. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70756-620-10
11-Digit CMS (5-4-2)
70756-0620-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.